Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Anesthesiology
|
February 7, 2020
Insights into the Chemical Discovery of Remifentanil
Paul L Feldman
International Journal of Toxicology
|
December 17, 2020
Development and Regulatory Challenges for Peptide Therapeutics
Doris Zane, Paul L Feldman, Tomi Sawyer, et al.
Drug Discovery Today
|
July 18, 2016
Quality guidelines for oral drug candidates: dose, solubility and lipophilicity
Martin K Bayliss, James Butler, Paul L Feldman, et al.
Microbiology Spectrum
|
June 30, 2021
A 28-Day Toxicity Study of Tenofovir Alafenamide Hemifumarate by Subcutaneous Infusion in Rats and Dogs
Doris Zane, Shane Roller, Josephine Shelton, et al.
Plos One
|
April 5, 2014
Gut hormone pharmacology of a novel GPR119 agonist (GSK1292263), metformin, and sitagliptin in type 2 diabetes mellitus: results from two randomized studies
Derek J Nunez, Mark A Bush, David A Collins, et al.
Anesthesiology
|
June 23, 2007
CNS 7056: a novel ultra-short-acting Benzodiazepine
Gavin J Kilpatrick, Margaret S McIntyre, Richard F Cox, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 10, 2002
Identification and structure-activity studies of novel ultrashort-acting benzodiazepine receptor agonists
Jeffrey A Stafford, Gregory J Pacofsky, Richard F Cox, et al.
Anesthesiology
|
April 17, 2004
Preclinical pharmacology of GW280430A (AV430A) in the rhesus monkey and in the cat: a comparison with mivacurium
John J Savarese, Matthew R Belmont, Mir A Hashim, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 10, 2002
Relating the structure, activity, and physical properties of ultrashort-acting benzodiazepine receptor agonists
Gregory J Pacofsky, Jeffrey A Stafford, Richard F Cox, et al.
Journal of Medicinal Chemistry
|
November 28, 2006
Potent, selective, and orally efficacious antagonists of melanin-concentrating hormone receptor 1
Francis X Tavares, Kamal A Al-Barazanji, Eric C Bigham, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Anesthesiology
|
February 7, 2020
Insights into the Chemical Discovery of Remifentanil
Paul L Feldman
International Journal of Toxicology
|
December 17, 2020
Development and Regulatory Challenges for Peptide Therapeutics
Doris Zane, Paul L Feldman, Tomi Sawyer, et al.
Drug Discovery Today
|
July 18, 2016
Quality guidelines for oral drug candidates: dose, solubility and lipophilicity
Martin K Bayliss, James Butler, Paul L Feldman, et al.
Microbiology Spectrum
|
June 30, 2021
A 28-Day Toxicity Study of Tenofovir Alafenamide Hemifumarate by Subcutaneous Infusion in Rats and Dogs
Doris Zane, Shane Roller, Josephine Shelton, et al.
Plos One
|
April 5, 2014
Gut hormone pharmacology of a novel GPR119 agonist (GSK1292263), metformin, and sitagliptin in type 2 diabetes mellitus: results from two randomized studies
Derek J Nunez, Mark A Bush, David A Collins, et al.
Anesthesiology
|
June 23, 2007
CNS 7056: a novel ultra-short-acting Benzodiazepine
Gavin J Kilpatrick, Margaret S McIntyre, Richard F Cox, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 10, 2002
Identification and structure-activity studies of novel ultrashort-acting benzodiazepine receptor agonists
Jeffrey A Stafford, Gregory J Pacofsky, Richard F Cox, et al.
Anesthesiology
|
April 17, 2004
Preclinical pharmacology of GW280430A (AV430A) in the rhesus monkey and in the cat: a comparison with mivacurium
John J Savarese, Matthew R Belmont, Mir A Hashim, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 10, 2002
Relating the structure, activity, and physical properties of ultrashort-acting benzodiazepine receptor agonists
Gregory J Pacofsky, Jeffrey A Stafford, Richard F Cox, et al.
Journal of Medicinal Chemistry
|
November 28, 2006
Potent, selective, and orally efficacious antagonists of melanin-concentrating hormone receptor 1
Francis X Tavares, Kamal A Al-Barazanji, Eric C Bigham, et al.
Page
of 2